Lyophilization method and apparatus for producing particles
US Patent & TradeMark Office
United States Patent Application 20040154317
Kind Code A1
Shekunov, Boris Y. ; et al. August 12, 2 READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050002998
Kind Code A1
Chang, Esther H. ; et al. January 6, 2005
Abstract
A method for preparing a stable cell-targeting complex comprising a ligand an READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20040191754
Kind Code A1
Meir, Uri ; et al. September 30, 2004
Abstract
A method and a device for improved freezing of biological containing living cells READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20040043042
Kind Code A1
Johnson, Audrey M. ; et al. March 4, 2004
Abstract
Methods and systems are provided for microscale lyophilization or microscale READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20040009609
Kind Code A1
Yarborough, Cody L. ; et al. January 15, 2004
Abstract
A process for lyophilizing a solution of an active agent in a container i READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20030104068
Kind Code A1
Mathiowitz, Edith ; et al. June 5, 2003
Abstract
A process is provided for making dry, micronized particles of an agent, such as READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20030099714
Kind Code A1
Dasseux, Jean-Louis May 29, 2003
Abstract
The invention relates to the formation of peptide/lipid vesicles and complexes through th READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20030068416
Kind Code A1
Burgess, Wilson ; et al. April 10, 2003
Abstract
The present invention relates to an improved method for lyophilization or freez READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20020114737
Kind Code A1
Madril, Dominic G. ; et al. August 22, 2002
Abstract
The present invention provides a cover plate that covers one or more delive READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20020042388
Kind Code A1
Cooper, Mark J. ; et al. April 11, 2002
Abstract
Counterions of polycations used to compact nucleic acids profoundly affect shape READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20010001348
Kind Code A1
Wisniewski, Richard May 24, 2001
Abstract
Disclosed are bulk lyophilization containers including aseptic closure portions or heat READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
ABSTRACT:
A lyophilization closure assembly for a container or vial is disclosed. The lyophilization closure assembly is self-supporting with the container and may be employed with the container d READ MORE http://patents1.ic.gc.ca/details...
ABSTRACT:
Somatotropin solutions which remain clear for extended periods
and which remain clear when subjected to mechanical agitation are
prepared by mixing a lyophilized somatotropin composi READ MORE http://patents1.ic.gc.ca/details...
(12) Patent Application: (11) CA 2375779
ABSTRACT:
Freeze dried preparations containing hepatocyte growth factor (HGF), a stabilizer such as arginine or lysine, sodium chloride and a buffer. T READ MORE http://patents1.ic.gc.ca/details...
(12) Patent Application: (11) CA 2410468
ABSTRACT:
A syringe system requires a decreased vertical travel for sealing during a lyophilization process and therefore provides for increased utiliz READ MORE http://patents1.ic.gc.ca/details...
(12) Patent Application: (11) CA 2252374
ABSTRACT:
A process for the viral inactivation of lyophilized blood proteins, particularly Factor VIII, by heat comprising forming a stable complex bet READ MORE http://patents1.ic.gc.ca/details...
12) Patent Application: (11) CA 2420095
ABSTRACT:
The invention relates to methods of protecting microorganisms against lethal and sub-lethal damage caused by exposure to low temperatures. Pro READ MORE http://patents1.ic.gc.ca/details...
12) Patent Application: (11) CA 2173601
ABSTRACT:
A method is provided for the formation of liposomes of 0.1 ?m to 50 ?m in diameter having unilamella or multilamella structure and containing READ MORE http://patents1.ic.gc.ca/details...
ABSTRACT:
This invention relates to the improvement of arrays of porous polymer pads on solid supports used in biological assays. The invention involves freeze drying the porous polymer pads to in READ MORE http://patents1.ic.gc.ca/details...
(12) Patent Application: (11) CA 2178496
ABSTRACT:
The present invention relates to a lyophilization process and a cap (10) intended for vials or use therewith for containers that are subjecte READ MORE http://patents1.ic.gc.ca/details...
(12) Patent Application: (11) CA 2140971
ABSTRACT:
The present invention provides a freeze dried pharmaceutical composition comprising hirudin and a water-soluble salt of calcium and/or magnes READ MORE http://patents1.ic.gc.ca/details...
(12) Patent Application: (11) CA 2079895
ABSTRACT:
2079895 9113301 PCTABS00007 This invention introduces an absorption vapor pressure
enhancement operation. In the process, a mass of solvent READ MORE http://patents1.ic.gc.ca/details...
(12) Patent Application: (11) CA 2485827
ABSTRACT:
Lyophilized preparations from cell extract for use in cell-free protein, which exhibit an activity for protein synthesis being in no way infe READ MORE http://patents1.ic.gc.ca/details...
(12) Patent Application: (11) CA 2275153
ABSTRACT:
A pharmaceutical composition comprising a nucleotide analogue, mannitol and a modifying additve which is sodium chloride or a polyol which is READ MORE http://patents1.ic.gc.ca/details...
12) Patent Application: (11) CA 2253974
ABSTRACT:
A process for the preparation of freeze dried liposome encapsulated amphiphilic drug compositions, which process comprises preparing a liposom READ MORE http://patents1.ic.gc.ca/details...
(12) Patent Application: (11) CA 2135265
ABSTRACT
A stable lyophilized composition of the antitumor alkylating agent thiotepa and a method of preparing such a composition via co-lyophilization o READ MORE http://patents1.ic.gc.ca/details...
(12) Patent Application: (11) CA 2012853
Abstract: FREEZE-DRIED POLYMER DISPERSIONS AND THE USE THEREOF IN PREPARING SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITIONS
Freeze-dried polymer latices, w READ MORE http://patents1.ic.gc.ca/details...
12) Patent Application: (11) CA 2392810
ABSTRACT:
The present invention relates to a novel freeze - dried pharmaceutical composition useful for the treatment of migraine and associated symptom READ MORE http://patents1.ic.gc.ca/details...
(12) Patent Application: (11) CA 2231682
ABSTRACT:
A preparation relating to a PGE1-containing fat emulsion with excellent qualities which is superior to the conventional ones bacteriologicall READ MORE http://patents1.ic.gc.ca/details...
(12) Patent Application: (11) CA 2119096
ABSTRACT OF THE DISCLOSURE:
There is disclosed a lyophilized control or reference plasma or control or reference serum for diagnostic purposes containing READ MORE http://patents1.ic.gc.ca/details...
(12) Patent Application: (11) CA 2454587
ABSTRACT:
This invention is directed to a stable lyophilized pharmaceutical formulation prepared by lyophilizing an aqueous formulation comprising a hi READ MORE http://patents1.ic.gc.ca/details...
12) Patent Application: (11) CA 2333505
ABSTRACT:
Vaccine stabilizers, vaccine formulations and lyophilized vaccines with enhanced thermostability are disclosed. The vaccine formulations compr READ MORE http://patents1.ic.gc.ca/details...
(12) Patent Application: (11) CA 2280130
ABSTRACT:
An object of the invention is to improve the solubility of a glycosphingolipid having a low solubility in water by preparing a freeze-dried c READ MORE http://patents1.ic.gc.ca/details...
12) Patent Application: (11) CA 2223749
ABSTRACT:
A freeze-dried composition containing TPO which comprises thrombopoietin (TPO) protein and saccharides as pharmaceutically acceptable additive READ MORE http://patents1.ic.gc.ca/details...
(12) Patent Application: (11) CA 2199018
ABSTRACT:
A method of forming a lyophilized liposome product by combining a lipid with an aqueous solution containing a drying protectant, without addi READ MORE http://patents1.ic.gc.ca/details...
12) Patent Application: (11) CA 2461187
ABSTRACT:
A freeze-dried preparation for injection which makes a cis[((1R,2R)-1,2cyclohexanediamine-N,N')bis(R1)]platinum(II) (R1 represents C6-20 alkan READ MORE http://patents1.ic.gc.ca/details...
United States Patent Application 20050037085
Kind Code A1
Jones, David Hugh ; et al. February 17, 2005
Microencapsulated DNA for vaccination and gene therapy
Abstract
A microparticle c READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050002965
Kind Code A1
Yun, Chae-Ok ; et al. January 6, 2005
Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comp READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20040116345
Kind Code A1
Besman, Marc ; et al. June 17, 2004
Novel albumin-free factor VIII formulations
Abstract
A Factor VIII composition formulated READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050109046
Kind Code A1
Irvine, J. David ; et al. May 26, 2005
Method and apparatus for the manipulation and management of a cryogen for production of fr READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20030099674
Kind Code A1
Chen, Andrew X. May 29, 2003
Lyophilized injectable formulations containing paclitaxel or other taxoid drugs
Abstract
A stable a READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20030077208
Kind Code A1
Ikenoue, Masaki ; et al. April 24, 2003
Holder for freeze-drying of drug solutions
Abstract
A holder comprises a base 1 having READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050032192
Kind Code A1
Vesey, Graham ; et al. February 10, 2005
Products containing quantum of bioparticles and method for production thereof
Abstract READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20040151736
Kind Code A1
Sikora, Christopher A. ; et al. August 5, 2004
Use of cross-protection to identify novel vaccine candidates for infectious agents READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20030147897
Kind Code A1
Andersen, Peter ; et al. August 7, 2003
M. tuberculosis antigens
Abstract
The present invention is based on the identification READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20030059435
Kind Code A1
Gallili, Gilad ; et al. March 27, 2003
Vaccine composition and method of using the same
Abstract
The present invention relates READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20030049717
Kind Code A1
Vesey, Graham ; et al. March 13, 2003
Products comprising quantum of bioparticles and method for production thereof
Abstract
A READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20020182226
Kind Code A1
Peetermans, Julien ; et al. December 5, 2002
Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto alum READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20020176867
Kind Code A1
Andersen, Peter ; et al. November 28, 2002
Hybrids of M. tuberculosis antigens
Abstract
The present invention discloses fusion READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20020120228
Kind Code A1
Maa, Yuh-Fun ; et al. August 29, 2002
Powder compositions
Abstract
A gel-forming free-flowing powder suitable for use as a vac READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20020065483
Kind Code A1
Leon, Nathaniel ; et al. May 30, 2002
Disposable unit-dose jet-injection syringe for pre-filled and/or transfilled liquid injecta READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050084534
Kind Code A1
Ni, Yawei ; et al. April 21, 2005
Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
Abstrac READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20020085999
Kind Code A1
Lee, Lucy F. ; et al. July 4, 2002
Marek's disease virus genes and their use in vaccines for protection against marek's disease
READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20040235956
Kind Code A1
Quay, Steven C. November 25, 2004
Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20040213798
Kind Code A1
Maa, Yuh-Fun ; et al. October 28, 2004
Spray-dried alum compositions
Abstract
A gel-forming free-flowing powder suitable for u READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20040213745
Kind Code A1
Sullivan, Vincent ; et al. October 28, 2004
Powder formulations of rSEB for improved vaccination
Abstract
A method of preparin READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20030202978
Kind Code A1
Maa, Yuh-Fun ; et al. October 30, 2003
Spray freeze-dried compositions
Abstract
A process for producing a powder comprises spr READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050113446
Kind Code A1
Keri, Vilmos ; et al. May 26, 2005
Method of purifying pravastatin
Abstract
The present invention provides pure pravastatin co READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050112206
Kind Code A1
Watanabe, Shunsuke ; et al. May 26, 2005
Pharmaceutical composition for oral use with improved absorption
Abstract
The present READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050112201
Kind Code A1
Baichwal, Anand R. ; et al. May 26, 2005
Delayed release dosage forms
Abstract
A delayed release pharmaceutical formulation co READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050112193
Kind Code A1
Phillips, Jeffrey O. ; et al. May 26, 2005
Immediate-release formulations of acid-labile pharmaceutical compositions
Abstract
READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050112188
Kind Code A1
Eliaz, Rom Ezer ; et al. May 26, 2005
Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle
Abs READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050106246
Kind Code A1
Byrd, Edward A. May 19, 2005
Controlled release arginine alpha-ketoglutarate
Abstract
An oral formulation of arginine .alpha.-ke READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050106240
Kind Code A1
Tanaka, Nobukazu ; et al. May 19, 2005
Composition for rapid disintegrating tablet in oral cavity
Abstract
The present inventi READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050107382
Kind Code A1
Brown, Alan Daniel ; et al. May 19, 2005
Substituted triazole derivatives as oxytocin antagonists
Abstract
The present inventi READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050106238
Kind Code A1
Wuthrich, Patrick ; et al. May 19, 2005
Orodispersible pharmaceutical composition comprising ivabradine
Abstract
The invention READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050106237
Kind Code A1
Wuthrich, Patrick ; et al. May 19, 2005
Orodispersible pharmaceutical composition comprising perindopril
Abstract
The inventio READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050100590
Kind Code A1
Duena, Antonio Parent ; et al. May 12, 2005
Liposomes encapsulating anticancer drugs and use thereof in the treatment of malignan READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050085494
Kind Code A1
Daines, Robert A ; et al. April 21, 2005
Aminopiperidine compounds, process for their preparation, and pharmaceutical composition READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050084537
Kind Code A1
Martyn, Glen Patrick ; et al. April 21, 2005
Sustained-release compositions
Abstract
Microparticles comprise a therapeutic age READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050064028
Kind Code A1
Hegedus, Lajos ; et al. March 24, 2005
Pharmaceutical compositions containing plasma protein
Abstract
The invention is related READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050048083
Kind Code A1
Colau, Brigitte Desiree Alberte ; et al. March 3, 2005
Vaccine
Abstract
The invention provides a method of inducing an immune READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050124646
Kind Code A1
Okuhara, Masakuni ; et al. June 9, 2005
Tricyclo compounds, a process for their production and a pharmaceutical composition conta READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050130978
Kind Code A1
Yuda, Masamichi ; et al. June 16, 2005
Novel crystal of quinoxalinedione derivative anhydride
Abstract
The object of the prese READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050130980
Kind Code A1
Paruch, Kamil ; et al. June 16, 2005
Novel imidazopyrazines as cyclin dependent kinase inhibitors
Abstract
In its many embodim READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050131217
Kind Code A1
Tsien, Roger Y. ; et al. June 16, 2005
Synthetic molecules that specifically react with target sequences
Abstract
The present READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050152977
Kind Code A1
Petereit, Hans-Ulrich ; et al. July 14, 2005
Abstract
The invention relates to a process for producing a coated drug form or a d READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050154116
Kind Code A1
Nagy, Janos B. ; et al. July 14, 2005
Nanocomposite: products, process for obtaining them and uses thereof
Abstract
The presen READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050154004
Kind Code A1
Banwell, Martin Gerhardt ; et al. July 14, 2005
Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, n READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050153999
Kind Code A1
Hu, Mengwei July 14, 2005
Pharmaceutical compositions
Abstract
Disclosed are pharmaceutical compositions comprising NK.sub.1 Ant READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050153980
Kind Code A1
Schadt, Oliver ; et al. July 14, 2005
Substituted indoles
Abstract
Substituted indoles of the formula (I) and physiologically READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050153964
Kind Code A1
Leach, Andrew Colin ; et al. July 14, 2005
Novel compounds
Abstract
Compounds of formula (I): 1 are inhibitors of the enzyme L READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050153902
Kind Code A1
Staehle, Wolfgang ; et al. July 14, 2005
Inhibitors of integrin avb6
Abstract
Novel biphenyl derivatives of the general formul READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050153894
Kind Code A1
Zheleva, Daniella I. ; et al. July 14, 2005
p21 peptides
Abstract
The present invention relates to p21 derived peptides capabl READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050153888
Kind Code A1
Ronn, Lars Christian ; et al. July 14, 2005
NCAM binding compounds
Abstract
The invention provides novel compounds which are c READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050153404
Kind Code A1
Bosch, Boris ; et al. July 14, 2005
Anti-kazlauskas lipases
Abstract
The present invention relates to polypeptides which exert READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050153329
Kind Code A1
Hakansson, Leif ; et al. July 14, 2005
Method for determining immune system affecting compounds
Abstract
The present invention READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050152985
Kind Code A1
Janusz, Marin ; et al. July 14, 2005
Colostrinin, and uses thereof
Abstract
The use of Colostrinin as a medicament, particular READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050148613
Kind Code A1
Van Emelen, Kristof ; et al. July 7, 2005
Carbonylamino-derivatives as novel inhibitors of histone deacetylase
Abstract
This i READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050148507
Kind Code A1
Wandl, Robert ; et al. July 7, 2005
Method for the production of an N-terminally modified chemotactic factor
Abstract
The inve READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050153018
Kind Code A1
Ubbink, Johan Bernard ; et al. July 14, 2005
Probiotic delivery system
Abstract
The present invention relates to a probiotic d READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050152962
Kind Code A1
Metselaar, Josbert Maarten July 14, 2005
Composition for treatment of inflammatory disorders
Abstract
A pharmaceutical compositi READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050143419
Kind Code A1
Peyman, Anuschirwan ; et al. June 30, 2005
--------------------------------------------------------------------------------
Guan READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050143393
Kind Code A1
Dean, David Kenneth ; et al. June 30, 2005
Pleuromutilin derivatives with antimicrobial activity
Abstract
Pleuromutilin compou READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050143368
Kind Code A1
Starke, Ingemar ; et al. June 30, 2005
Chemical compounds
Abstract
The present invention relates to compounds of formula (1): READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050143290
Kind Code A1
Rademacher, Thomas William ; et al. June 30, 2005
Substituted inositols and their use
Abstract
Inositol phosphate esters and c READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050142214
Kind Code A1
Brown, Dennis M. June 30, 2005
Naphthalimide compositions and uses thereof
Abstract
A method of treatment of a host with a cellu READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050137167
Kind Code A1
Casu, Benito ; et al. June 23, 2005
Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed wit READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050131071
Kind Code A1
Wuthrich, Patrick ; et al. June 16, 2005
Orodispersible pharmaceutical composition of agomelatine
Abstract
The invention relat READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050124589
Kind Code A1
Roessler, Berthold June 9, 2005
New use, pharmaceutical preparations as well as a process for their production
Abstract
The inve READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050124586
Kind Code A1
Phan, Hieu Trung ; et al. June 9, 2005
Alpha-substituted arylalkyl phosphonate derivatives
Abstract
The present invention rela READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050124581
Kind Code A1
Phan, Hieu Trung ; et al. June 9, 2005
Alpha-substituted heteroarylalkyl phosphonate derivatives
Abstract
The present inventio READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050123918
Kind Code A1
Carroll, Miles ; et al. June 9, 2005
Mhc class I peptide epitopes from the human 5t4 tumor-associated antigen
Abstract
There i READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050119172
Kind Code A1
Merkle, Werner June 2, 2005
Stabilization of protein preparations
Abstract
A composition comprising a non-albumin protein is sta READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050118597
Kind Code A1
Carroll, Miles ; et al. June 2, 2005
Peptide II
Abstract
There is provided an MHC class II peptide epitope from 5T4 antigen. I READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050107365
Kind Code A1
Becker, Cyrus Kephra ; et al. May 19, 2005
Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
Abstract
This READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050136010
Kind Code A1
Haeberlin, Barbara June 23, 2005
Aerosol composition comprising formoterol
Abstract
The use of dry powder comprising (A) formate READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
United States Patent Application 20050123593
Kind Code A1
Thompson, Jonathan ; et al. June 9, 2005
Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints
Ab READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
Method of treating mammalian joint maladies by biological fluid transplantation
US PATENT & TRADEMARK OFFICE
United States Patent Application 20060083787
Kind Code A1
Meader; Charles P. ; READ MORE http://appft1.uspto.gov/netacgi/nph-Parser...
Dry powder inhaler system
European Patent Office
Publication number: US2006254583
Publication date: 2006-11-16
Inventor: DEBOECK ARTHUR (US); BAUDUER PHILIPPE (BE)
Applicant:
Classificati READ MORE http://v3.espacenet.com/textdoc...